SCHEMBL18679381

SCHEMBL18679381

Cc1cccc(-c2cc(-c3cc(C)c(-n4c5ccc(N(c6ccccc6)c6ccccc6)cc5c5cc(N(c6ccccc6)c6ccccc6)ccc54)cc3C)nc(-c3cccc(C)c3)n2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I3 Q14994 1/20 0.34
RAB9A P51151 4/20 0.33
ALDH1A1 P00352 3/20 0.33
NPC1 O15118 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KMT2A Q03164 8/20 0.32
MEN1 O00255 5/20 0.32
MAPT P10636 4/20 0.32
LMNA P02545 4/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18679334 0.94 ALDH1A1 (0.33) NR1I3RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL18679265 0.94 ALDH1A1 (0.33) NR1I3RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL18679748 0.92 NR1I3 (0.34) NR1I3RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL18679688 0.91 NR1I3 (0.33) NR1I3RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL18679357 0.91 MEN1 (0.35) RAB9AALDH1A1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL18679361 0.89 NR1I3 (0.36) NR1I3RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL18679336 0.89 MAPT (0.34) NR1I3RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL18679389 0.88 ALDH1A1 (0.36) RAB9AALDH1A1NPC1SMN1; SMN2L3MBTL1
SCHEMBL18679770 0.88 MEN1 (0.33) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL18679270 0.88 MAPT (0.33) NR1I3RAB9AALDH1A1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200243773-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2020-07-30 US disclosed
US-10651392-B2 Organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-05-12 US disclosed
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-03-30 US disclosed
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10651392-B2 Organic light-emitting device OR10J3, L1CAM, EML4 NR1I3 1347/4885RAB9A 2065/4885ALDH1A1 50/4885
US-20200243773-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, L1CAM, EML4 NR1I3 1347/4885RAB9A 2065/4885ALDH1A1 50/4885
US-20170092872-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, L1CAM, EML4 NR1I3 1347/4885RAB9A 2065/4885ALDH1A1 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.